NanoEnTek announced on September 1, 2026, that it has decided to acquire KRW 5 billion worth of its own shares to enhance shareholder returns and increase corporate value.


On this day, NanoEnTek's board of directors resolved to proceed with the share buyback. The number of shares to be acquired is 1,273,885 shares based on the closing price from the previous day. The shares will be purchased through a trust agreement by buying them on the open market, with the transaction set to proceed for approximately six months, from September 1, 2026, until February 28, 2027.


The company explained that this buyback aims to share the results of the company’s performance growth with shareholders and to stabilize the stock price and enhance corporate value.


NanoEnTek plans to cancel all shares acquired through this buyback. The specific timing of the cancellation will be decided through a future resolution of the board of directors.



A NanoEnTek official stated, "We plan to strengthen our competitiveness in the Life Science (LS) and In Vitro Diagnostics (IVD) markets, while expanding shareholder-friendly management through this share buyback," adding, "We will further enhance corporate value through transparent governance and a diverse set of shareholder return policies."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing